Todays Market Nifty  8,786.20 (+41.85) ( +0.48%)

Sensex   28,452.17 (+109.16) (+0.39%)

CPPIB gets RBI nod to up stake in Kotak Mahindra Bank upto 10%

 Private sector lender Kotak Mahindra Bank today said the Reserve Bank had granted approval to Canada Pension Plan Investment Board to buy stake in excess of 5 percent and up to 10 percent in the bank.

Private sector lender Kotak Mahindra Bank   today said the Reserve Bank had granted approval to Canada Pension Plan Investment Board to buy stake in excess of 5 percent and up to 10 percent in the bank. "The Reserve Bank of India has informed that the bank that it has granted approval to Canada Pension Plan Investment Board (CPPIB) for acquiring shares in excess of 5 per cent and below 10 per cent of the paid up capital," Kotak Mahindra Bank said in a regulatory filing to stock exchanges. CPPIB has picked up stake of the bank from Japanese multinational Sumitomo Mitsui Banking Corp (SMBC) through open market operation earlier this year. CPPIB bought 1.81 crore shares from SMBC. As per the norms, a foreign investor cannot own more than 10 per cent in the private sector bank. Banks (including foreign banks having branch presence in India) can continue to acquire stake in a bank's equity shares up to 10 per cent of the investee bank's equity capital. However, in case of exceptional circumstances, such as, restructuring of problem/weak banks or in the interest of consolidation in the banking sector, etc., Reserve Bank may permit them a higher level of shareholding.

Kotak Mahindra Bank gets RBI approval for acquisition of shares by Canada Pension Plan Investment Board

Kotak Mahindra Bank announced that the Reserve Bank of India has informed the Bank that it has granted approval to Canada Pension Plan Investment Board (CPPIB) for acquiring shares in excess of 5% and below 10% of the paid up capital of Kotak Mahindra Bank.

Todays Market Nifty  8,744.35 (+136.90) (+1.59%)

Sensex    28,343.01 (+440.35) (+1.58%)

Cipla gets USFDA nod for generic anti-depressant drug

"InvaGen Pharmaceuticals Inc has received final approval for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride extended release tablets (XL), 150 mg and 300 mg, from the United States Food and Drug Administration," Cipla said in a statement.

Drug firm Cipla   today said its US arm InvaGen Pharmaceuticals Inc has received final approval from the American health regulator to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder. "InvaGen Pharmaceuticals Inc has received final approval for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride extended release tablets (XL), 150 mg and 300 mg, from the United States Food and Drug Administration," Cipla said in a statement. The product is available for shipping immediately, it added. The company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said. "The tablets are indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD)," it added. Wellbutrin XL tablets and generic equivalents had US sales of approximately USD 792 million for the 12 month period ending June 2016, according to IMS Health, Cipla said. Shares of Cipla were today trading at Rs 570.25 per scrip in the afternoon trade on BSE, up 0.54 percent from its previous close.

Todays Market Nifty 8607.45 (+34.90) (+0.41%)

Sensex 27902.66 (+120.41) (+0.43%)

Airtel cuts 4G price by up to 80%
In a move to counter Reliance Jio, telecom major Bharti Airtel   has slashed 4G and 3G mobile internet charges by up to 80 per cent to as low as Rs 51 per gigabyte (GB) under a special scheme. To avail this benefit, Airtel customers will have to recharge with Rs 1,498 against which they will get 1GB of 4G or 3G mobile internet usage valid for 28 days, the company said in a statement. Post exhaustion of 1GB data limit, the customers can get 1GB 4G or 3G recharges for just Rs 51 over a period of 12 months and there is no limit on the number of recharges during the period. At present, Airtel offers 1GB of 3G or 4G mobile internet for Rs 259 valid for 28 days. The company is also set to launch a similar scheme in lower denomination of Rs 748. Under this scheme, Airtel customers will get 1GB of 4G for Rs 99 over a period of six months. "These prepaid packs are live in Delhi and will get launched across circles by Aug 31, 2016," the statement said. "With these innovative packs, we are redefining the value proposition on our data packs and allowing our customers get a lot more within the same budget," Bharti Airtel Director - Operations (India & South Asia), Ajai Puri said. Airtel in July started offering up to 67 percent more data in existing 4G and 3G schemes which was followed by Idea Cellular and Vodafone. In August, Airtel made voice calling free even in roaming under a new plan for Rs 1,199 which also included 1GB of 3G or 4G data depending on availability of network. Players like Airtel and Idea have upped the ante in mobile data pricing ahead of the upcoming commercial launch by Reliance Jio. The company had said it has over 1.5 million test users on its network. Reliance Jio, which is gearing up to launch its 4G services, had also said during the recently-concluded quarter, it extended its trial services to all LYF devices users under the Jio LYF Preview Offer. 

Todays Market Nifty  8,572.55  (-19.65) (0.23%)

 Sensex  27,782.25 (-53.66) (-0.19%)

FDA warns former Sun Pharma U.S. drug factory over quality concerns

The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical (SUN.NS) drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.

This is one of a series of quality concerns tied to the Philadelphia, Pennsylvania factory that the FDA highlighted in an Aug. 15 "warning letter" issued to the site's current owner, U.S. firm Frontida BioPharm Inc.

The plant was sold to Frontida in June by Sun, India's No. 1 drugmaker, which said the move was "a part of its manufacturing consolidation in the U.S."

Sun did not mention at the time that the FDA had inspected the plant a year earlier, between June 15 and July 17, 2015, or that it expressed serious concerns with its quality standards.

Details of the inspection were released in the warning letter posted on the FDA site this week.

Sun declined to comment on the FDA letter, while Frontida was not immediately reachable for comment on Friday.

India supplies more than 30 percent of the drugs sold in the United States, and Sun is one of several Indian companies that are under the FDA's scanner for quality issues, after the agency increased the frequency of foreign inspections over the past two years.

At least five of Sun's plants are barred from U.S. exports due to quality issues, and the company has said it is working on improving its quality systems to get back U.S. approval to supply from them.

The FDA letter is addressed to Frontida Chief Executive Sung Li, and does not mention Sun or any of its executives.

In the letter, the U.S. regulator also outlined "multiple discrepancies" that it said cast doubt on the accuracy of the quality-related records maintained at the factory.

In another observation, the FDA said that factory staff was aware by April 2015 that the chemical benzophenone had leached into some tablets of the hypertension drug felodipine from the ink and varnish on the container label, but the lots were not recalled until the FDA inspection in July 2015

Todays Market Nifty 8,592.20 (-58.10) (-0.67%)

Sensex  27,835.91 (-224.03) (-0.80%)

ITC gains as foreign brokerage maintains outperform rating

Meanwhile, the BSE Sensex was down 176.27 points, or 0.63%, to 27,883.67

On BSE, so far 5.99 lakh shares were traded in the counter, compared with an average volume of 8.71 lakh shares in the past one quarter. The stock hit a high of Rs 254.95 and a low of Rs 250.50 so far during the day. The stock hit a 52-week high of Rs 262 on 2 August 2016. The stock hit a 52-week low of Rs 178.67 on 29 February 2016. The stock had underperformed the market over the past 30 days till 24 August 2016, slipped 0.54% compared with Sensexs 0.3% rise. The scrip had also performed the market in past one quarter, gaining 3.59% as against Sensexs 6.42% rise.

The large-cap company has an equity capital of Rs 1209.96 crore. Face value per share is Re 1.

The foreign brokerage has reportedly stated in a research note that lower price hike will support ITCs cigarette volume growth. The companys earnings are likely to grow at a compound annual growth rate (CAGR) of 14% over FY 2016 to FY 2019, the brokerage reportedly said.

Meanwhile, ITC during market hours today, 25 August 2016, issued a clarification regarding news reports that it has moved court against Britannia Industries (Britannia) for copying biscuit packaging. ITC said that it has filed a suit against Britannia before the Delhi High Court as Britannia has copied the trade dress and colour combination of ITCs Sunfeast Farmlite Digestive ALL Good biscuit packages for its Britannia Nutrichoice Digestive Zero biscuit packages. The case was filed by the company on 20 August 2016 and will be coming up for hearing on 31 August 2016, ITC said.

Shares of Britannia Industries rose 0.98% at Rs 3,470. The company in its clarification issued after market hours yesterday, 24 August 2016, said that ITC has filed a suit against the company at Delhi High Court alleging that Britannia is copying the color combination of ITCs Sunfeast Farmlite Digestive All Good Biscuit Packs for its Nutrichoice Digestive Zero biscuit packs. The matter came up for hearing before Delhi High Court on 22 August 2016 and 24 August 2016. The next date of hearing is 31 August 2016. No injunction (stay) has been granted as of now. As the matter is sub-judice, the company cannot comment further on this matter, Britannia Industries said.

ITCs after net profit rose 10.09% to Rs 2384.67 crore on 10.07% increase in total income to Rs 10474.56 crore in Q1 June 2016 over Q1 June 2015.

ITC is a diversified company, with presence in cigarettes, hotels, paperboards & specialty papers, packaging, agri-business, packaged foods & confectionery, information technology, branded apparel, personal care, stationery and other FMCG products. ITC is a market leader in cigarettes.

Todays Market Nifty 8650.30 (+17.70) (+0.21%)

Sensex 28059.94 (+69.73) (+0.25%)

Infosys gains on reports of likely win of about $60 million GST project

Meanwhile, the S&P BSE Sensex was up 50.79 points or 0.18% at 28,041

On BSE, so far 95,000 shares were traded in the counter as against average daily volume of 2.81 lakh shares in the past one quarter. The stock hit a high of Rs 1,060 and a low of Rs 1,045 so far during the day. The stock had hit a 52-week low of Rs 1,009.20 on 22 August 2016. The stock had hit a record high of Rs 1,278 on 3 June 2016. The stock had underperformed the market over the past 30 days till 23 August 2016, falling 3.82% compared with Sensexs 0.37% fall. The scrip had also underperformed the market in past one quarter, sliding 14.03% as against Sensexs 8.15% rise.

The large-cap company has equity capital of Rs 1148.47 crore. Face value per share is Rs 5.

As per reports, Infosys may get about $60 million (Rs 400 crore) in incremental revenue over the third and fourth quarters of the current financial year (FY 2017) as part of the Rs 1380 crore Goods Services and Tax Network (GSTN) project. Under the ongoing GSTN project, Infosys has started importing hardware, including servers and network equipment devices, payment for which will be made by GSTN starting October this year, reports suggested.

On a consolidated basis, Infosys net profit fell 4.5% to Rs 3436 crore on 1.4% growth in revenue to Rs 16782 crore in Q1 June 2016 over Q4 March 2016. The results are as per International Financial Reporting Standards (IFRS).

Infosys is one of the leading information technology outsourcing services providers. The company provides business consulting, information technology and outsourcing services.

Todays Market Nifty 8,632.60 (+3.45) (+0.04%)

 Sensex 27,990.21 (+4.67) (+0.02%)

Reliance Infra concludes sale of cement subsidiary

Reliance Infrastructure, a part of the Anil Ambani-led group, on Monday said it has concluded a 100-per cent sale of its cement company to Birla Corp. The deal values the company's cement business at 4,800 crore, or Rs 140 per tonne, the company said.

"Reliance Cement Company has an integrated capacity of 5.08 million tonnes per annum at Maihar in Madhya Pradesh and Kundanganj in Uttar Pradesh and a grinding unit of 0.5 Mtpa at Butibori in Maharashtra. The entire proceeds shall be utilised for debt reduction," the company said.

Reliance Infra had announced its plan to monetise its cement, roads and Mumbai power businesses to reduce the overall debt. State Bank of India Capital Markets acted as the financial advisors to for the sale transaction, the company said.

Birla Corp, established in 1919, is part of the MP Birla Group with presence in cement and jute. 

Cement constitutes over 90 per cent of the company's revenues, with a total operational cement capacity of over 10 million tonnes per annum with units in Rajasthan, Madhya Pradesh, Uttar Pradesh and West Bengal.

Todays Market Nifty 8,629.15 (-37.75) (-0.44%)

Sensex  27,985.54 (-91.46) (-0.33%)

Jindal Steel & Power : JSPL secures Long-term Coal Linkage for 540+134 MW Captive Power Plant at Raigarh,

JSPL secures Long-term Coal Linkage for 540+134 MW Captive Power Plant at Raigarh, Chhattisgarh Bagged 1.18 MTPA Coal Linkage in recent Linkage auctions for CPP

New Delhi. 22 August 2016: Jindal Steel and Power Ltd. (JSPL) has secured long-term linkage of 1.18 Million Tonne Per Annum for its state-of-the-art captive power generation plants in Dongamahua and Raigarh in Chhattisgarh. The long-term coal linkage for a period of 5 years has been secured during the recent coal linkage auctions. The long-term linkage will ensure steady and assured supply of coal for the captive power plants, thereby enhancing the Fuel Security for the power plants.

"The 1.18 MTPA Coal linkage to our captive power generation facility significantly enhances the operational efficiencies of the power plants. In line with our philosophy, our prudent bids ensure that we get constant supply of coal for a period of 5 years", said Mr. Ravi Uppal, MD & Group CEO - JSPL. "We are looking forward to the next round of coal linkage auctions to fill the gap, and would selectively participate to further enhance our long-term Fuel Security requirements at prudent terms of our Steel and Power businesses", Mr. Uppal added.

About Jindal Steel and Power Limited (JSPL):

Jindal Steel and Power Limited (JSPL) is one of India's fastest growing and largest integrated steel manufacturers, significantly present in Steel, Power Generation and Infrastructure segments and catering to a large part of India's domestic energy and infrastructure requirement. Part of the US$ 18 billion diversified O. P. Jindal Group, JSPL's business operations span across Asia, Africa and Australia.

Led by Shri Naveen Jindal, the youngest son of the legendary Shri O.P. Jindal, the company produces economical and efficient steel and power through backward and forward integration. From the widest flat products to a whole range of long products, JSPL today has a product portfolio that caters to markets across the steel value chain. JSPL provides employment opportunities to over 22,000 Indians and anchors a socio-economic eco system for over 100,000 families

Todays Market Nifty  8,666.90 (-6.35) (-0.07%)

 Sensex  28,077.00 (-46.44) (-0.17%)

Vedanta CEO says response from Cairn India shareholders to sweetened bid positive

Vedanta Ltd's chief executive said the diversified Indian miner received "constructive feedback" from minority shareholders in Cairn India Ltd to a sweetened buyout offer, and was hopeful it can clinch the long-delayed deal.

"We have reached out to all shareholders and we have held constructive discussions across the board ... We look forward to the vote in the coming weeks," said Vedanta Chief Executive Tom Albanese, speaking in an interview with Reuters on Friday.

Last month, Vedanta revised the terms of an offer aimed at buying out the minority stake in Cairn India that it does not already own, after an initial offer stalled and a deal remained in limbo for months.

Albanese, the former head of global miner Rio Tinto PLC, also said the company has not received any inquiry from Indian markets regulator, Securities and Exchange Board of India (SEBI), with regard to movement in the stock prices of the two companies leading up to the announcement of the revised bid.

On Thursday, Indian newspaper Mint reported that SEBI was investigating unusual movement in shares of Cairn and Vedanta ahead of the announcement of the sweetened offer.

Albanese said the company has "clear and robust" policies against insider trading and that it would cooperate fully if it did receive a request for information from the regulator.

Any such probe would not delay the timeline of the Cairn deal, he added.

The shareholders of Vedanta and Cairn will be voting on the revised offer on Sept. 8 and Sept. 12 respectively. Vedanta plans to close the transaction by end of March 2017.

Analysts note the acquisition would give Vedanta direct access to Cairn's $3.5 billion cash pile, and some have expressed concern that Vedanta may use this toward paring its own $11 billion debt rather than investing in growth projects.

Albanese said the board of directors of the combined entity would decide on how to use the cash, and that Vedanta does not have any debt maturing until mid-2018.

India Cements gains after good Q1 result

The result was announced during market hours today, 18 August 2016.

Meanwhile, the S&P BSE Sensex was up 126.09 points or 0.45% at 28,131.46

On BSE, so far 17.30 lakh shares were traded in the counter as against average daily volume of 5.11 lakh shares in the past one quarter. The stock hit a high of Rs 130.80 so far during the day, which is a 52-week high for the counter. The stock had hit a 52-week low of Rs 63.60 on 25 August 2015. The stock had outperformed the market over the past 30 days till 17 August 2016, rising 11.25% compared with 0.78% rise in the Sensex. The scrip also outperformed the market in past one quarter, surging 43.61% as against Sensexs 10.26% rise.

The mid-cap company has equity capital of Rs 307.18 crore. Face value per share is Rs 10.

India Cements is one of the largest producers of cement in South India.

Todays Market Nifty 8673.25 (+49.20) (+0.57%) Sensex 28123.44 (+118.07) (+0.42%)

Government slaps Rs-2500 crore  additional penalty on Reliance Industries

Government has slapped an additional penalty of US $380 million (around Rs 2,500 crore) on Reliance Industries and its partners for producing less than targeted natural gas from eastern offshore KG-D6 fields.

With this, the total penalty, which is in form of disallowing recovery of cost incurred, for missing the target in five fiscal years beginning April 1, 2010, now stands at a cumulative US $ 2.76 billion.

Lupin tops most reputed pharma brand list

Domestic pharma majors Lupin, Sun Pharma and Ciplahave dominated the list of top reputed pharmaceuticals brand survey released today. 

City-based Lupin Pharmaceuticals tops in reputation leading the country's most reputed pharmaceutical brands' list, as per 'Top Most Reputed Pharmaceutical Brand' study conducted by BlueBytes in association with TRA Research.

Sun Pharmaceutical, with a 52 per cent Brand Rep Score and Cipla with 28 per cent bagged the second and third spots, followed by Dr Reddy's Laboratories at fourth. 

Among global brands, GSK led the way, followed by Pfizerand Abbott. In all, 41 domestic and 17 international pharmaceutical brands were listed in the study. 

"India's reputation as the largest producer of generic drugs in the world has become vulnerable in light of the changing patent regime in the country. Reports say that by 2020,India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size," said Pooja Kaura, chief spokesperson for India's Most Reputed Brands

Todays  Market Nifty  8,624.05 (-18.50) (-0.21%)

Sensex  28,005.37 (-59.24) (-0.21%)

Suzlon Energy receives repeat order from ReNew Power

For 132 MW wind power project in Andhra Pradesh

Suzlon Energy has received an repeat turnkey order for 132 MW from ReNew Power. The order comprises of suzlon's latest product offerings and includes 15 units of S97 90m tubular tower and 48 units of S97 120m Hybrid Tower with a rated capacity of 2.1MW each. The project will be commissioned in Andhra Pradesh by March 2017. The project is capable of providing power to over 70,000 households and reducing 0.28 million tonnes of CO2 emissions per annum.

Todays Market Nifty  8,642.55 (-29.60) (-0.34%)

 Sensex  28,064.61 (-87.79) (-0.31%)

JSW Steel to acquire JSW Praxair Oxygen for Rs. 240 cr

Sajjan Jindal-led JSW Steel today said it will acquire 74 per cent stake in JSW Praxair Oxygen Pvt Ltd (JPOPL) for Rs. 240 crore in cash.

JPOPL produces industrial gases such as oxygen, nitrogen and argon. It has two air separation plants, each with a capacity of 2,500 tonnes per day, in Bellary district of Karnataka.

“JSW Steel has executed a share purchase agreement with Praxair India to acquire their entire shareholding of 74 per cent in JPOPL for a cash consideration of Rs. 240 crore,” it said in a regulatory filing.

JSW Steel holds 26 per cent of the equity shares of JPOPL and post the aforesaid acquisition, JPOPL would become a wholly-owned subsidiary of the company, it added.

The firm sources industrial gases from JPOPL, amongst others, at prices based on long-term contracts.

“The said acquisition is strategic in nature as it will provide the company the benefit of backward integration of this critical input,” JSW Steel said.

Deloitte Touche Tohmatsu India LLP and Bharucha & Partners, Advocates and Solicitors, carried out the financial and legal due diligence, respectively, for the company, it added.

Shares of JSW Steel were trading at Rs. 1,746.05, up 1.23 per cent during the pre-close session on the BSE

Todays Market Nifty 8672.15 (+80.00) (+0.93%)

Sensex 28152.40 (+292.80) (+1.05%)

 AB Nuvo to merge with Grasim; swap ratio at 100:30

The shareholders of AB Nuvo, for every 100 shares, will get 30 shares of the Grasim. Post the initial merger of the two companies, financial services business of the AB Nuvo will come into ABFSL, in which shareholders will get 210 shares.
The boards of AB Nuvo and Grasim have entered into a two-way restructuring process to merge AB Nuvo into Grasim. The shareholders of AB Nuvo, for every 100 shares will get 30 shares of Grasim.  The first step involves merging AB Nuvo with Grasim following which the financial services business of AB Nuvo will come into Aditya Birla Financial Services (ABFSL). ABFSL is expected to be listed on stock exchanges post the merger. Shareholders of AB Nuvo will get 210 shares in ABFSL for every 100 shares post the listing while the Grasim shareholders, holding 100 shares, will get 700 shares in the financial business.

Glenmark Q1 profit up 24%, US biz grows 24% but margin shrinks

Mumbai-based healthcare company Glenmark Pharma   started off financial year 2016-17 on a strong note with earnings beating analysts' expectations on Friday. Consolidated profit surged 24 percent year-on-year to Rs 226.8 crore on strong revenue and other income but slow operational performance limited growth. Consolidated revenue in Q1 grew by 18 percent to Rs 1,943 crore on yearly basis, led by good growth across all operating regions except Latin America and out-licensing income. "The US business continues to perform well and the recent approvals for the business will ensure the growth momentum will continue. Europe business performed well due to strong growth witnessed by the UK subsidiary," Glenn Saldanha, chairman & MD said.

Todays Market Nifty 8,592.15 (+16.85) (+0.20%) Sensex 27,859.60 (+84.72) (+0.31%)

Bank of Baroda Q1 net dives 60% to Rs 424 crore

Public sector Bank of Baroda Thursday reported a massive 60 per cent plunge in its standalone net profit at Rs 423.62 crore for the first quarter ended June 2016, hit by higher provisions for bad loans and contingencies.

The bank had a net profit of Rs 1,052.15 crore on standalone basis in the corresponding quarter a year ago.

"Total income decreased to Rs 11,877.91 crore for the quarter ended June 2016 from Rs 12,243.720 crore in the quarter ended June 30, 2015," it said in a regulatory filing.

The bank said it made a profit of Rs 424 crore while moving from a loss position in the previous two quarters.

Both gross and net non performing assets (NPAs) rose over two times as a percentage of advances during the first quarter of the current fiscal.

Gross NPAs were 11.15 per cent of gross advances as of June 2016, up from 4.13 per cent a year ago, and in absolute terms rose to Rs 42,991.68 crore as against Rs 17,273.95 crore a year earlier.

Net NPAs stood at 5.73 per cent (Rs 20,783.77 crore), up from 2.07 per cent (Rs 8,470.02 crore).

We wrote  yesterday  be cautious today will be big day, just see what happen in nifty .

Today we wrote after 12:50 market will bounce back just check nifty taken support of 50Day average of 8640 and closed above 8675 .

This happen only because of chart there is no magic no miracle in this market just follow trend and have trade setup you will be good trader.

And  WILL FALL IN LOVE WITH STOCK  MARKET

Things turnout best for those ....

Who have made the best out of the way the things have turned out .  

Todays Market Nifty 8678.25   (-33.10) (-0.38%)

Sensex  28085.16 ( -97.41)  (-0.35%)

Lupin Q1 net profit up 55% YoY; sales below estimates

LupinBSE -5.03 % reported 55 per cent year-on-year (YoY) growth in the net profit to Rs 882 crore for the quarter ended June 30 which was above ET Now estimate of Rs 795 crore. 

The pharma major reported a net profit of Rs 569 crore in the year-ago period. 

Total sales rose by 40 per cent on a YoY basis to Rs 4,314 crore which was slightly below ET Now estimate of Rs 4,415 crore. It reported total sales of Rs 3,081 crore in the corresponding of last fiscal. 

Welcome back !!!  Great week started  congratulation all of you  market starts positive today after struggling beetween 30 points .

But it has taken 8700 support and bounced to close above 8715 ,

Well as per our trading support we have made following best trades Todays Top Trade Profit

Those who says we are not able to make money from market . Just need patience and technical setup , nothin else trading with setup will creat your wealth instead of wasting time on social media ,reading pink papers ,or watching blue channels,

We says everything will happen only when you start a good way.

Market given opportunities to all of us but only few of them grabbing the same .

Tomorrow will be big day let's see  be alert don't miss Adani rec .  YOU ARE WHERE YOU ARE AND WHAT YOU ARE BECAUSE OF YOURSELF - No one ELSE.  

Banking, auto, and realty stocks in spotlight ahead of RBI policy meeting

Interest rate sensitive banking, auto and realty stocks will be watched ahead of the Reserve Bank of Indias (RBI) monetary policy meeting today, 9 August 2016. Purchases of automobiles, including that of cars, utility vehicles and commercial vehicles are substantially driven by financing. Purchases of both residential and commercial property are largely driven by finance. The central bank had left its benchmark repo rate unchanged at 6.5% in its last meeting.

Among key corporate earnings, Adani Ports and Special Economic Zone (APSEZ) and Lupin are scheduled to announce Q1 June 2016 earnings today, 9 August 2016.

Idea Cellulars consolidated net profit slumped 74.21% to Rs 220.41 crore on 7.22% rise in total income to Rs 9552.44 crore in Q1 June 2016 over Q1 June 2015. The result was announced after market hours yesterday, 8 August 2016.

HDFC after market hours yesterday, 8 August 2016 announced that a committee of the board of directors of the company at its meeting held yesterday, 8 August 2016, approved the entering into definitive agreements for amalgamation of business between HDFC Standard Life Inusrance Company (HDFC Life), Max Life Insurance Company (Max Life) and Max Financial Services (Max Financial) through a composite scheme of srrangement. As a part of the proposed transaction, the life insurance business of Max Financial, currently held through Max Life, would be finally amalgamated with HDFC Life and all other business of Max Financial would be finally amalgamated into Max India. The shares of HDFC Life are proposed to be listed on BSE and the National Stock Exchange of India (NSE) as a consequence of the scheme. Pursuant to the scheme and subject to receipt of the requisite approvals, the shareholding of HDFC in HDFC Life post completion of the proposed transaction would be 42.5% and consequently HDFC Life would cease to be a subsidiary of HDFC.

For the merger of Max Life into Max Financial, shareholders of Max Life will get one share of Max Financial for approximately five shares of Max Life. For the demerger of the life insurance undertaking from Max Financial into HDFC Life, shareholders of Max Financial (post the amalgamation with Max Life), will get 2.33 shares of HDFC Life for each share of Max Financial.

Tata Motors announced that its group global wholesales rose 20% to 88,159 units in July 2016 over July 2015. The announcement was made after market hours yesterday, 8 August 2016.

Rural Electrification Corporation (REC) announced that it has scheduled a board meeting on 11 August 2016, to consider issue of bonus shares. The announcement was made after market hours yesterday, 8 August 2016.

Sun Pharmaceutical Industries (Sun Pharma) announced the extension of its Imatinib Mesylate Savings Card Program beyond 31 July 2016. Sun Pharma launched this program as part of the Imatinib Mesylate launch in February 2016. The program is aimed at delivering greater access to the drug by patients who have commercial insurance, but whose out-of-pocket cost may exceed an affordable amount. The announcement was made after market hours yesterday, 8 August 2016.

Skipper announced after market hours yesterday, 8 August 2016 that the board of directors gave in-principal approval for setting up of a new unit for engineering products and polymer moulded products at Guwahati, Assam, with an investment of around Rs 70 crore. The unit will be the companys fourth unit for engineering products and sixth unit for polymer products. The installed capacity for the proposed unit will be 30,000 tonnes for engineering products and 7,000 tonnes for polymer products.

Shriram Transport Finance Company announced after market hours yesterday, 8 August 2016 that the Allotment Committee - Non-Convertible Debentures (NCDs) of the company in its meeting held on 8 August 2016 approved and allotted 1,100 secured redeemable NCDs of face value of Rs. 10 lakh each, aggregating to Rs 110 crore on private placement basis. The NCDs have tenure of ten years and carry a coupon rate of 8.87% per annum. The NCDs have a call option after 4 years from the date of allotment.

Arvind announced after market hours yesterday, 8 August 2016 that Credit Analysis & Research (CARE) has revised upwards its rating for the companys long-term bank facilities from CARE A+ to CARE AA- and reaffirmed its rating for short-term bank facilities of CARE A1+.

LIC Housing Finance turns ex-dividend today, 9 August 2016 for dividend of Rs 5.50 per share for the year ended 31 March 2016 (FY 2016).

Bharti Infratel turns ex-dividend today, 9 August 2016 for final dividend of Rs 3 per share for the year ended 31 March 2016 (FY 2016).

Heritage Foods turns ex-dividend today, 9 August 2016 for dividend of Rs 3 per share for the year ended 31 March 2016 (FY 2016).

Hello hope you enjoyed last week and minted tons of money ? What's now ? RBI policy Nifty 9000 and bloodbath 👼 .

Nifty has taken 20 day ma support and going towards 9000 level.

Tuesday will be high volatile day in Indian stock market , we seen very good strength in market but soon will cooled off likely .

Position we have in Vedanta coal India M&M finance  Adani port pnb .

Need to be cautious at certain levels , tomorrow market may open  up to 50 points if Asian market support. It's very good time to book profit every bull run gas some base time . Need to find out the same . So will get many opportunities to play very successful game this market be ready to grab the opportunity . 

Todays Market Nifty 8711.35 (+28.20) (+0.32%)

Sensex 28182.57 (+104.22) (+0.37%)

Colgate-Palmolive (India) standalone net profit rises 8.44% in the June 2016 quarter

Net profit of Colgate-Palmolive (India) rose 8.44% to Rs 125.72 crore in the quarter ended June 2016 as against Rs 115.94 crore during the previous quarter ended June 2015. Sales rose 8.87% to Rs 1005.59 crore in the quarter ended June 2016 as against Rs 923.70 crore during the previous quarter ended June 2015.

Global Offshore Services standalone net profit declines 55.60% in the June 2016 quarter

Net profit of Global Offshore Services declined 55.60% to Rs 2.42 crore in the quarter ended June 2016 as against Rs 5.45 crore during the previous quarter ended June 2015. Sales declined 19.25% to Rs 31.29 crore in the quarter ended June 2016 as against Rs 38.75 crore during the previous quarter ended June 2015.

ParticularsQuarter Endedn++Jun. 2016Jun. 2015% Var. Sales31.2938.75 -19 OPM %39.9538.99 - PBDT8.1210.80-25 PBT2.495.49 -55 NP2.425.45 -56

As mentioned on 2/08/2016 we said 3rd session will be high volatile session . Just see nifty today's gain closed near 8700 mark.

It was a great week we have for minting money . Kai far weekly gainer inour portfolio is Vedanta Canara bank Adani ongcs  and lots of stocks .we have done very good transaction  in these script we congratulate all of you  who made lots of money this week.

Now next week biggest event for the market is RBI policy . Which will create volatility , nifty taking very good support on 20 day MA. And helping us predict market  accurately.

 Market will keep going always only you are the person who are responsible about the trade "Change is the law of life And those who look only to the past or present are certain to miss the future.."

Todays Market Nifty 8683.15 (+132.05) (+1.54%)

Sensex 28078.35 (+363.98) (+1.31%)

Axis Bank announces appointment of director

Axis Bank announced that the Reserve Bank of India vide its letter dated 04 August 2016 has approved the appointment of Rajiv Anand as Whole-Time Director designated as Executive Director (Retail Banking) and Shri Rajesh Dahiya as Whole-Time Director designated as Executive Director (Corporate Centre) of the Bank, for a period of 3 years, with effect from 04 August 2016.

Cadila Healthcare completes acquisition of two ANDAs from Teva

Cadila Healthcare announced the acquisition of two ANDAs by its 100% subsidiary, Zydus Worldwide DMCC from Teva that were being divested by Teva as a pre-condition to its acquisition of Allergans generic business. The acquisition of these ANDAs was contingent on the closing of the Teva-Allergan Generics transaction and approval by the US Federal Trade Commission.

Siemens gains on strong growth in order intake in Q3

Meanwhile, the S&P BSE Sensex was up 251.66 points, or 0.91%, to 27,966.03.

On BSE, so far 17,000 shares were traded in the counter, compared with an average daily volume of 26,231 shares in the past one quarter. The stock hit a high of Rs 1,291.90 and a low of Rs 1,250 so far during the day. The stock hit a record high of Rs 1,558 on 6 August 2015. The stock hit a 52-week low of Rs 969 on 29 January 2016. The stock had underperformed the market over the past one month till 4 August 2016, falling 2.60% compared with 1.60% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 10.60% as against Sensexs 10.41% rise.

The large-cap company has equity capital of Rs 71.22 crore. Face value per share is Rs 2.

Shares of Siemens had edged lower ahead of Q3 results. The stock fell 6.06% in three trading sessions to settle at Rs 1,254.70 yesterday, 4 August 2016, from its close of Rs 1,335.65 on 1 August 2016.

Siemenss net profit fell 22.72% to Rs 130.03 crore on 8.81% increase in total income to Rs 2648.28 crore in Q3 June 2016 over Q3 June 2015. The company said in its Q3 June 2016 results press release that the decline in bottom line on year on year basis in Q3 June 2016 was mainly due to one-time costs and adverse exchange rates.

Sunil Mathur, managing director and chief executive officer Siemens said that the company has delivered a satisfactory financial performance in a difficult economic environment. New orders continued to flow from railways, transmission and distribution projects though private sector capex is still muted, he added.

Siemens has declared a special interim dividend of Rs 27.50 per equity share for the year ending 30 September 2016 as it received funds from the sale of its healthcare undertaking. The company has sold the healthcare undertaking as a going concern on a slump sale basis to Siemens Healthcare, a subsidiary of parent Siemens AG, Germany. The gains on the sale will be reflected in the results for Q4 September 2016, the company said in a statement. The stock offers a dividend yield of 2.19% based on the closing price of Rs 1,254.70 yesterday, 4 August 2016.

The company has fixed 17 August 2016 as the record date for the purpose of payment of special dividend. The payment of special dividend will commence from 23 August 2016.

Siemens focuses on the areas of electrification, automation and digitalization

Todays Market Nifty 8551.10 (+6.25) (+0.07%)

Sensex 27714.37 (+16.86) (+0.06%)

Arvind standalone net profit rises 11.32% in the June 2016 quarter

Net profit of Arvind rose 11.32% to Rs 87.45 crore in the quarter ended June 2016 as against Rs 78.56 crore during the previous quarter ended June 2015. Sales rose 13.08% to Rs 1466.54 crore in the quarter ended June 2016 as against Rs 1296.90 crore during the previous quarter ended June 2015.

BASF India standalone net profit declines 87.45% in the June 2016 quarter\

Net profit of BASF India declined 87.45% to Rs 9.81 crore in the quarter ended June 2016 as against Rs 78.16 crore during the previous quarter ended June 2015. Sales rose 3.51% to Rs 1389.96 crore in the quarter ended June 2016 as against Rs 1342.85 crore during the previous quarter ended June 2015.

Todays Market Nifty 8,544.85 (-78.05) (-0.91%) Sensex 27,697.51 (-284.20) (-1.02%)
Capital First consolidated net profit rises 48.43% in the June 2016 quarter
Net profit of Capital First rose 48.43% to Rs 49.16 crore in the quarter ended June 2016 as against Rs 33.12 crore during the previous quarter ended June 2015. Sales rose 55.97% to Rs 616.08 crore in the quarter ended June 2016 as against Rs 395.00 crore during the previous quarter ended June 2015.
Titan Company standalone net profit declines 16.35% in the June 2016 quarter
Net profit of Titan Company declined 16.35% to Rs 126.69 crore in the quarter ended June 2016 as against Rs 151.45 crore during the previous quarter ended June 2015. Sales rose 3.56% to Rs 2782.50 crore in the quarter ended June 2016 as against Rs 2686.76 crore during the previous quarter ended June 2015.